Abilify in Bipolar Disorder for 24 Weeks Treatment Effectiveness

Clinical trial NCT00545675 · COMPLETED

Trial details

NCT number: NCT00545675
Sponsor: Korea Otsuka Pharmaceutical Co., Ltd.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Bipolar Disorder

Start date: 2007-12-01
Primary completion: 2010-07-01
Enrollment: 146

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.